Posted by Michael Wonder on 06 Jun 2017
Workshop: addressing unmet needs of children with pulmonary arterial hypertension
6 June 2017 - The EMA, the United States FDA and Health Canada are co-organising a workshop to discuss the requirements for the development of medicines for pulmonary arterial hypertension that address the high unmet medical needs of children.
The event will take place at EMA’s premises in London on 12 June 2017, and a live broadcast will be available on the EMA website.
The workshop will bring together leading experts and stakeholders in pulmonary arterial hypertension across the globe – including regulators, researchers, clinicians, healthcare professionals, patients and pharmaceutical industry representatives.
